Robert Lippert is listed as an executive officer and director on 3 SEC Form D filings by 2 issuers between Jul 2010 and Apr 2016: CONJUGON INC (Madison, WI — biotechnology — 2015–2016; $1.93M reported sold to 14 investors) and Ratio, Inc. (Monona, WI — pharmaceuticals — 2010; $343K reported sold to 6 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 6 years. Across those companies the filings report $2.27M sold in total.
Listed alongside Carl Spalding (2 shared filings), Gary Noskin (2 shared filings), H. Thomas Watkins (2 shared filings), Paul T. Evans (2 shared filings), Richard Burgess (2 shared filings) and 5 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 10 bankruptcy cases matching the name listed in Key records below.
What this means 10 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for Robert Lippert and found 9 differences, 3 worth asking the sponsor about: 287% of the money raised went to insiders; 51% of the money raised went to insiders; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.